News

3SBio has posted a net income of $3.94m for the third quarter 2010, or $0.03 per diluted share, compared to net income of $3.35m, or $0.02 per diluted

Hospira‘s Gemcitabine is approved by the US Food and Drug Administration (FDA) for treatment of a variety of cancers. Hospira claimed that it will be the first company

DelRx has proprietary platform drug delivery technology for transmucosal administration of large molecule drugs as a liquid dispersion, e.g., peptides like insulin, monoclonal antibodies, hormones, vaccines and other

Sunesis Pharma said that Vosaroxin is an anticancer quinolone derivative, or AQD, a class of compounds that has not been used previously for the treatment of cancer. According

Discovered and developed by Eisai, Halaven is a non-taxane, microtubule dynamics inhibitor and a synthetic analog of halichondrin B, a natural product isolated from the marine sponge Halichondria

Cielo chief medical officer Donald Nease said that in Phase I, they successfully studied and documented the needs and expectations of primary care practices and providers regarding web-based

Chiltern said that SAFE is a complete electronic Trial Master File (TMF) solution which facilitates remote management of documents, which saves administrative time and increases accuracy and security

The acquisition is likely to enhance ITT’s Analytics business, formed earlier this year with the acquisition of Nova Analytics. ITT Analytics is a manufacturer of field, portable, laboratory

Under the terms of the collaboration, which is supported by a grant from the UK East Midlands Development Agency, London Genetics and Astrimmune will put together a proposal